Drug profile · INN
trimeprazine tartrate
TEMARIL
trimeprazine tartrate (TEMARIL) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — trimeprazine tartrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
trimeprazine tartrate (TEMARIL) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is trimeprazine tartrate?
trimeprazine tartrate (TEMARIL) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trimeprazine tartrate?
TEMARIL is a marketed brand name for trimeprazine tartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trimeprazine tartrate?
trimeprazine tartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.